Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA

Reuters
2025.09.15 14:41
portai
I'm PortAI, I can summarize articles.

JAMJOOM PHARMACEUTICALS FACTORY COMPANY SJSC :JAMJOOM PHARMA - STRIKES STRATEGIC DEAL WITH BIO-THERA FOR SECURING COSENTYX BIOSIMILAR IN MENAJAMJOOM PHARMA - UNDER DEAL, CO WILL OBTAIN EXCLUSIVE RIGHTS TO COMMERCIALIZE BAT2306 ACROSS MENA REGIONJAMJOOM PHARMA WILL MANAGE REGULATORY SUBMISSIONS, MARKET ACCESS, AND COMMERCIALIZATION IN MENABIO-THERA WILL OVERSEE PRODUCT DEVELOPMENT AND GLOBAL MANUFACTURING FROM ITS STATE-OF-THE-ART FACILITIES IN GUANGZHOU, CHINA

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.